News

Novo Nordisk launches weight-loss drug Wegovy in India to compete with Lilly's Mounjaro
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...
Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds
Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...
Novo Nordisk’s New Obesity Drug Beats Wegovy Weight Loss in Early Trial
Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.
Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly's Mounjaro
By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Danish drugmaker Novo Nordisk launched its blockbuster weight-loss ...
Novo Nordisk follows smart pricing for Wegovy in India; easy to use, says top local executive
We wanted to price it in India in a way which is comparable to the therapies that are available,' said Vikrant Shrotriya, ...
pharmaphorum1d
ADA: Novo continues effort to rehabilitate CagriSema
Presenting results from the REDEFINE 1 and REDEFINE 2 studies at the American Diabetes Association (ADA) congress in Chicago, ...
24/7 Wall St.4d
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (June 2025)
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
GlobalData on MSN6d
Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes
Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...